The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A hepatocyte growth factor antagonist engineered by site-directed mutagenesis.
F. Cecchi
No relevant relationships to disclose
D. Pajalunga
No relevant relationships to disclose
A. Fowler
No relevant relationships to disclose
D. C. Rabe
No relevant relationships to disclose
B. Peruzzi
No relevant relationships to disclose
N. J. MacDonald
No relevant relationships to disclose
D. K. Blackman
No relevant relationships to disclose
S. j. Stahl
No relevant relationships to disclose
A. Byrd
No relevant relationships to disclose
D. P. Bottaro
No relevant relationships to disclose